Evidence map›Paper›PMID 29027645›Full record

Observational studyInternational journal of clinical pharmacy2017

Preventive effect of pre-warming, hot compress, and pH adjustment in oxaliplatin-induced venous pain.

Hitoshi Kawazoe, Satomi Sumikawa, Kana Nakauchi, Yoshihiro Yakushijin, Yuji Yamamoto, Yuji Watanabe, Akihiro Tanaka, Hiroaki Araki

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in International journal of clinical pharmacy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Trial
  2. Preventive effect of hot compress on phlebitis during cisplatin and Vinorelbine treatment for non-small cell lung cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hitoshi KawazoeDivision of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan. hitoshik@m.ehime-u.ac.jp.
Satomi SumikawaDivision of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
Kana NakauchiDivision of Nursing, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
Yoshihiro YakushijinCancer Center, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
Yuji YamamotoDivision of Gastrointestinal Surgery and Surgical Oncology, Department of Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan.
Yuji WatanabeDivision of Gastrointestinal Surgery and Surgical Oncology, Department of Surgery, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, Japan.
Akihiro TanakaDivision of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
Hiroaki ArakiDivision of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, Ehime, Japan.
Ehime University Hospital · JPEhime University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Venous pain induced by peripheral intravenous administration of oxaliplatin remains clinically unresolved. Objective The aim of this study was to determine the efficacy of comprehensive intervention care for venous pain in colorectal cancer patients receiving oxaliplatin. Setting A Japanese tertiary hospital. Method We treated all outpatients after April 2012 with comprehensive intervention care including pre-warming of the oxaliplatin solution, use of a hot compress, and pH adjustment by combination with dexamethasone. We retrospectively reviewed the electronic medical records from colorectal cancer patients who had received oxaliplatin via a peripheral vein between December 2009 and June 2014. Main outcome measures The primary endpoint of this study was the incidence of venous pain at the administration site during oxaliplatin infusion, according to injection site reaction grade ≥ 2. Results We evaluated 271 treatment courses in 59 patients. Venous pain occurred in 42 courses (15.5%) among 26 patients. Multivariate logistic regression analysis revealed that female gender and body mass index ≥ 25 kg/m

Indexed as

Hydrogen-Ion ConcentrationAdministration, IntravenousAdultAgedColorectal NeoplasmsFemaleHot TemperatureHumansIncidenceJapanMaleMiddle AgedOrganoplatinum CompoundsOxaliplatinPainPain ManagementOrganoplatinum CompoundsOxaliplatinDexamethasoneHot compressOxaliplatinPre-warmingVenous pain

Identifiers

PMID29027645
OpenAlexW2761831425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.